Separation and isolation of metabolites of N-(4-hydroxyphenyl) retinamide (4-HPR) after incubation with Sprague-Dawley rat liver microsomes

被引：0
|
作者：
Malcolm, Emily K. [1 ]
Kelley, Melissa D. [1 ]
机构：
[1] Univ Cent Arkansas, Dept Chem, Conway, AR 72035 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2007年 / 233卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1053-CHED
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [31] Upregulation of gadd153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR)
    Xia, Y
    Wong, NS
    Fong, WF
    Tideman, H
    INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (01) : 7 - 14
  • [32] Chemotherapeutic evaluation of 4-hydroxybenzylretinone (4-HBR), a nonhydrolyzable C-linked analog of N-(4-hydroxyphenyl) retinamide (4-HPR) against mammary carcinogenesis
    Abou-Issa, H
    Curley, RW
    Alshafie, GA
    Weiss, KL
    Clagett-Dame, M
    Chapman, JS
    Mershon, SM
    ANTICANCER RESEARCH, 2001, 21 (6A) : 3839 - 3844
  • [33] HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production
    Simeone, AM
    Broemeling, LD
    Rosenblum, J
    Tari, AM
    ONCOGENE, 2003, 22 (43) : 6739 - 6747
  • [34] Inhibition by N-(4-hydroxyphenyl) retinamide of exogenous and endogenous liver carcinogenesis in rats
    Nakae, D
    Tamura, K
    Akai, H
    Kobayashi, Y
    Horiguchi, K
    Denda, A
    Konishi, Y
    RECENT ADVANCES IN GASTROENTEROLOGICAL CARCINOGENESIS I, 1996, : 1163 - 1166
  • [35] HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production
    Ann-Marie Simeone
    Lyle David Broemeling
    Josh Rosenblum
    Ana Maria Tari
    Oncogene, 2003, 22 : 6739 - 6747
  • [36] N-(4-hydroxyphenyl)all-trans-retinamide (4-HPR) high dose effect on DMBA-induced hamster oral cancer: a histomorphometric evaluation
    Lajolo, C.
    Giuliani, M.
    Sgambato, A.
    Majorano, E.
    Lucchese, A.
    Capodiferro, S.
    Favia, G.
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 37 (12) : 1133 - 1140
  • [37] Results of experimental bioassays on the chemopreventive effects of vitamin A and N-(4-hydroxyphenyl)-retinamide (HPR) on mammary cancer
    Soffritti, M
    Mobiglia, A
    Pinto, C
    Bortoluzzi, L
    Lefemine, G
    Maltoni, C
    SCIENTIFIC BASES OF CANCER CHEMOPREVENTION, 1996, 1120 : 241 - 248
  • [38] N-(4-HYDROXYPHENYL)RETINAMIDE - NEW RETINOID FOR PREVENTION OF BREAST-CANCER IN THE RAT
    MOON, RC
    THOMPSON, HJ
    BECCI, PJ
    GRUBBS, CJ
    GANDER, RJ
    NEWTON, DL
    SMITH, JM
    PHILLIPS, SL
    HENDERSON, WR
    MULLEN, LT
    BROWN, CC
    SPORN, MB
    CANCER RESEARCH, 1979, 39 (04) : 1339 - 1346
  • [39] The synthetic retinoid N-(4-hydroxyphenyl) retinamide (4-HPR) exerts antiproliferative and apoptosis-inducing effects in the androgen-independent human prostatic JCA-1 cells
    Hsieh, TC
    Ng, CY
    Wu, JM
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1995, 37 (03): : 499 - 506
  • [40] COX-2 is essential for HER2/neu to suppress N(4-hydroxyphenyl)retinamide (4-HPR) apoptosis in breast cancer cells.
    Tari, A
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1343S - 1344S
12345